OptimizeRx Corp (NAS:OPRX)
$ 10.54 -0.27 (-2.5%) Market Cap: 191.66 Mil Enterprise Value: 219.54 Mil PE Ratio: 0 PB Ratio: 1.51 GF Score: 77/100

Q4 2018 OPTIMIZERx Corp Earnings Call Transcript

Feb 26, 2019 / 09:30PM GMT
Release Date Price: $13.52 (-2.38%)
Operator

Good afternoon, and thank you for joining us today to discuss OptimizeRx's fourth quarter and full year ended December 31, 2018. With us today is the Chief Executive Officer of OptimizeRx, William Febbo. He is joined by the company's President, Miriam Paramore; and Chief Financial Officer, Doug Baker.

Following their remarks, we'll open the call to questions. Then, before we conclude today's call, I'll provide some important cautions regarding the forward-looking statements made by management during the call.

I'd like to remind everyone that today's call is being recorded and will be made available for telephone replay via instructions in today's press release in the Investors section of the company's website.

Now I would like to turn the call over to OptimizeRx CEO, William Febbo. Please go ahead, sir.

William J. Febbo
OptimizeRx Corporation - CEO & Director

Thank you, Justin, and good afternoon, everyone. Thanks for joining us on the call today. As you all saw from the earnings release we issued earlier today, we've made a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot